Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Endogene reinfection as a possible cause of recurrent genital candidose in female patients

View through CrossRef
The cause of primary, recurrent genital candidosis (RGC), that 5 % of the female population was afflicted with, is still unknown. It is not clear whether RGC is a result of reifection or infection recidive caused by Candida sp. The goal of the study is to examine Candida presence in women?s genital and intestinal tract; by resistotypization of the same isolated species of Candida fungi to prove their identity as well as the validity of the stated thesis that endogenous reinfection may be one of the possible causes of RGC. The study included 70 women (T-group) afflicted with primary RGC who, at the moment of the examination, were in the phase of manifest infection. In the control group there were 70 women (C-group) not afflicted with RGC. The microbiological test consisted of the microscopic and culture examination of women?s genital and intestinal material. The Candida species were differentiated according to the germination test and the biochemical activity measured by commercial Candi-Fast-test (Mycoplasma International France) and Vitec-AMS-system (bioMerieux, France). Candi-Fast test examined the sensitivity of Candida species to antymicotics and determined the resistotypes of isolated species. The study did not show statistically significant difference between examined groups in terms of the Candida presence in intestinal tract. The Candida colonization of intestinal mucosa was proved in 24 women (34.28 %) with RGC. Eighteen women (25.71 %) of the control group, had Candida sp. in intestinal tract. The most frequent RGC agent, as well as most frequent colonizer of intestinal mucosa is Candida albicans (C. albicans - RGC - 84.28 %; T-group - intestinal tract - C. albicans - 87.50 %; C-group - intestinal tract - C. albicans - 94.44 %). In 20 women with RGC there was a presence of identical resistotypes of isolated Candida sp. Identical resistotypes of C. albicans was found in 19 women of the test group, in their genital and intestinal tract. Only in one patient it was recorded the same resistance types of C. tropicalis. In four patients Candida species isolated from genital and intestinal material were not identical. In two women with RGC C. albicans on vaginal mucosa was accompanied by C. glabrata in intestinal tract, while in two more women the presence of various resistotypes C. albicans was identified in genital and intestinal tract.
Title: Endogene reinfection as a possible cause of recurrent genital candidose in female patients
Description:
The cause of primary, recurrent genital candidosis (RGC), that 5 % of the female population was afflicted with, is still unknown.
It is not clear whether RGC is a result of reifection or infection recidive caused by Candida sp.
The goal of the study is to examine Candida presence in women?s genital and intestinal tract; by resistotypization of the same isolated species of Candida fungi to prove their identity as well as the validity of the stated thesis that endogenous reinfection may be one of the possible causes of RGC.
The study included 70 women (T-group) afflicted with primary RGC who, at the moment of the examination, were in the phase of manifest infection.
In the control group there were 70 women (C-group) not afflicted with RGC.
The microbiological test consisted of the microscopic and culture examination of women?s genital and intestinal material.
The Candida species were differentiated according to the germination test and the biochemical activity measured by commercial Candi-Fast-test (Mycoplasma International France) and Vitec-AMS-system (bioMerieux, France).
Candi-Fast test examined the sensitivity of Candida species to antymicotics and determined the resistotypes of isolated species.
The study did not show statistically significant difference between examined groups in terms of the Candida presence in intestinal tract.
The Candida colonization of intestinal mucosa was proved in 24 women (34.
28 %) with RGC.
Eighteen women (25.
71 %) of the control group, had Candida sp.
in intestinal tract.
The most frequent RGC agent, as well as most frequent colonizer of intestinal mucosa is Candida albicans (C.
albicans - RGC - 84.
28 %; T-group - intestinal tract - C.
albicans - 87.
50 %; C-group - intestinal tract - C.
albicans - 94.
44 %).
In 20 women with RGC there was a presence of identical resistotypes of isolated Candida sp.
Identical resistotypes of C.
albicans was found in 19 women of the test group, in their genital and intestinal tract.
Only in one patient it was recorded the same resistance types of C.
tropicalis.
In four patients Candida species isolated from genital and intestinal material were not identical.
In two women with RGC C.
albicans on vaginal mucosa was accompanied by C.
glabrata in intestinal tract, while in two more women the presence of various resistotypes C.
albicans was identified in genital and intestinal tract.

Related Results

Incidence of COVID-19 reinfection among Midwestern healthcare employees
Incidence of COVID-19 reinfection among Midwestern healthcare employees
Abstract Importance Given the overwhelming worldwide rate of infection and the disappointing pace of vaccination, addressing re...
Outcomes of SARS-CoV-2 Reinfection
Outcomes of SARS-CoV-2 Reinfection
Abstract First infection with SARS-CoV-2 is associated with increased risk of acute and post-acute death and sequelae in the pulmonary and extrapulmonary organ systems. How...
Social media representation of female genital cutting: A YouTube analysis
Social media representation of female genital cutting: A YouTube analysis
Introduction: Female genital cutting is a practice that has incited controversy and conflicting discourses across the international community. There is a need t...
COVID-19 reinfection in Afghanistan: A descriptive analysis of data from DHIS2, 2022
COVID-19 reinfection in Afghanistan: A descriptive analysis of data from DHIS2, 2022
Background: Despite millions of COVID-19 infections worldwide since the beginning of the pandemic, relatively few confirmed cases of COVID-19 reinfection have been reported. In Afg...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Recurrence Possibility of COVID-19 in India
Recurrence Possibility of COVID-19 in India
Although nationwide lockdown was imposed in India amid COVID-19 outbreak since March 24, 2020, the COVID-19 infection is increasing day-by-day. India became world’s second most aff...

Back to Top